Author: | Tallman, M. |
Article Title: | Prognostic significance of molecular markers and targeted regimens in the management of acute myeloid leukemia |
Abstract: | The diagnosis, staging, and treatment of acute myeloid leukemia (AML) has evolved based on identification of important genetic alterations and drugs to target those genes. Cytogenetic abnormalities play a major role in managing AML. Achieving minimal residual disease is an increasingly important milestone. Four new targeted therapies are now available for the treatment of AML. © JNCCN-Journal of the National Comprehensive Cancer Network. |
Journal Title: | Journal of the National Comprehensive Cancer Network |
Volume: | 16 |
Issue: | 5 Suppl. |
ISSN: | 1540-1405 |
Publisher: | Harborside Press |
Date Published: | 2018-05-01 |
Start Page: | 656 |
End Page: | 659 |
Language: | English |
DOI: | 10.6004/jnccn.2018.0050 |
PROVIDER: | scopus |
PUBMED: | 29784749 |
DOI/URL: | |
Notes: | Conference Paper -- Export Date: 2 July 2018 -- Source: Scopus |